- Home
- LOAN vs GNTA Comparison
LOAN vs GNTA Comparison
Compare LOAN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOAN
- GNTA
- Stock Information
- Founded
- LOAN 1989
- GNTA 2014
- Country
- LOAN United States
- GNTA Italy
- Employees
- LOAN N/A
- GNTA N/A
- Industry
- LOAN Real Estate Investment Trusts
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOAN Real Estate
- GNTA Health Care
- Exchange
- LOAN Nasdaq
- GNTA Nasdaq
- Market Cap
- LOAN 61.0M
- GNTA 59.7M
- IPO Year
- LOAN 1999
- GNTA 2021
- Fundamental
- Price
- LOAN $4.93
- GNTA $2.81
- Analyst Decision
- LOAN
- GNTA
- Analyst Count
- LOAN 0
- GNTA 0
- Target Price
- LOAN N/A
- GNTA N/A
- AVG Volume (30 Days)
- LOAN 44.2K
- GNTA 1.9M
- Earning Date
- LOAN 10-24-2025
- GNTA 01-01-0001
- Dividend Yield
- LOAN 9.41%
- GNTA N/A
- EPS Growth
- LOAN N/A
- GNTA N/A
- EPS
- LOAN 0.46
- GNTA N/A
- Revenue
- LOAN $7,138,128.00
- GNTA N/A
- Revenue This Year
- LOAN N/A
- GNTA N/A
- Revenue Next Year
- LOAN $4.47
- GNTA N/A
- P/E Ratio
- LOAN $10.56
- GNTA N/A
- Revenue Growth
- LOAN N/A
- GNTA N/A
- 52 Week Low
- LOAN $4.74
- GNTA $2.33
- 52 Week High
- LOAN $6.05
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- LOAN 30.57
- GNTA 46.61
- Support Level
- LOAN $4.83
- GNTA $2.33
- Resistance Level
- LOAN $5.19
- GNTA $10.00
- Average True Range (ATR)
- LOAN 0.12
- GNTA 0.61
- MACD
- LOAN -0.04
- GNTA -0.07
- Stochastic Oscillator
- LOAN 18.88
- GNTA 7.05
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.